Celgene (NASDAQ:CELG) reported third quarter earnings that beat analyst's expectations on Thursday and revenue that topped forecasts.
The firm reported earnings per share of $2.29 on revenue of $3.89B. Analysts polled by anticipated EPS of $2.23 on revenue of $3.84B. That compared to EPS of $1.91 on revenue of $3.29B in the same period a year earlier. The company had reported EPS of $2.16 on revenue of $3.81B in the previous quarter.
Celgene shares gained 1.06% to trade at $75.50 in pre-market trade following the report.
For the year, Celgene shares are down 29.04%, under-performing the NASDAQ 100 which is up 5.56% year to date.
Celgene follows other major Healthcare sector earnings this month
On October 16, J&J (NYSE:JNJ) reported third quarter EPS of $2.05 on revenue of $20.35B, compared to forecasts of EPS of $2.03 on revenue of $20.04B.
Novartis ADR earnings beat analyst's expectations on October 18, with third quarter EPS of $1.32 on revenue of $12.78B. analysts expected EPS of $1.31 on revenue of $12.98B
Stay up-to-date on all of the upcoming earnings reports by visiting 's earnings calendar
